Track the 삼일제약 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 삼일제약 has logged 9 public disclosures. Market capitalisation: €155.2bn. The latest transaction was reported on 1 June 2026 (Purchase). Among the most active insiders: 허승범. The full history is openly available.
9
Insider Decl.
0
Thresholds
€39,049
5 ops.
Buy Volume
·
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 삼일제약 Strong Buy (bullish), based on 1 analysts. Average price target: ₩10,000.
30Σ signal
Buys €39,049· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 24,046 of 26,282 companies
20.4
score / 100
Value
16
Quality
25
FCF yld-5.2%
Earn yld-26%
EV/EBITDA·
ROE-25%
Gross mgn37%
Net mgn-16%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.